Alliqua Biomedical is a leading provider of advanced wound care solutions. The company is building a portfolio through targeted acquisitions and through licensing and distribution agreements with their strategic partner Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.
alliqua.com
alliqua.com
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Mentions in press and media 4
| Date | Title | Description |
| 19.11.2013 | Wound care licensing deal with Celgene latest development in biopharma’s evolution | The company changed CEOs earlier this year and relocated from New York to Langhorne, Pa. The company has two hydrogel wound dressings approved by the U.S. Food and Drug Administration, according to its website. Its SilverSeal wound dressing... |
| 13.11.2013 | Robin Hood Ventures leads $1.25m round in DreamIt grad PeerActive [Startup Roundup] | WHO’S GETTING FUNDED? Alliqua, a Langhorne, Pa. biotech company focused on wound care, raised $1 million from Boston-based Crossover Healthcare Fund, according to a release. Chris Sugden, managing partner at Edison Ventures, was named the N... |
| 06.01.2011 | Personnel moves: Cook Medical promotes Rusty Burns to global logistics and purchasing VP | Cook Medical promotes Rusty Burns to VP, global logistics and purchasing Rusty Burns, a 31-year veteran of Cook Inc., was promoted to VP of global logistics and purchasing. In his new role, Burns will manage all of Cook’s global warehousing... |
| - | Wound care licensing deal with Celgene latest development in biopharma’s evolution | Biopharmaceutical company Alliqua (OTC: ALQAD) has supplemented its wound care business in a $6 million licensing deal with Celgene’s cellular therapuetics division. It has also secured $13 million in new investment, according to a company ... |